Table 1 Frequency of the Val66Met (G196A) genotypes according to the risk of ED in preadolescence
ED severity | Val/Vala | Val/Metb | Met/Metc | p-value | p-value a vs b+c | ||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Â | n % (95% CI) | n % (95% CI) | n % (95% CI) | Â | Â | |||
| Â | Risk | 32 | 76.2 (60.6-87.9) | 9 | 21.4 (10.3-36.8) | 1 | 2.4 (0.0-12.6) | Â | Â |
Male | Diagnosis | 7 | 43.8 (19.8-70.1) | 7 | 43.8 (19.8-70.1) | 2 | 12.5 (1.6-38.3) | 0.181 | 0.099 |
| Â | Control | 22 | 64.7 (46.5-80.3) | 9 | 2 6.5 (12.9-44.4) | 3 | 8.8 (1.9-23.7) | Â | Â |
| Â | Risk | 28 | 68.3 (51.9-81.9) | 12 | 29.3 (16.1-45.5) | 1 | 2.4 (0.1-12.9) | Â | Â |
Female | Diagnosis | 17 | 73.9 (51.6-89.8) | 6 | 26.1 (10.2-48.4) | 0 | - | 0.562 | 0.527 |
| Â | Control | 25 | 61.0 (44.5-75.8) | 13 | 31.7 (18.1-48.1) | 3 | 7.3 (1.5-19.9) | Â | Â |
| Â | Risk | 60 | 72.3 (61.4-81.5) | 21 | 25.3 (16.4-36.0) | 2 | 2.4 (0.3-8.4) | Â | Â |
All | Diagnosis | 24 | 61.5 (44.6-76.6) | 13 | 33.3 (19.1-50.2) | 2 | 5.1 (0.6-17.3) | 0.433 | 0.199 |
| Â | Control | 47 | 62.7 (50.7-73.6) | 22 | 29.3 (19.4-41.0) | 6 | 8.0 (3.0-16.6) | Â | Â |